A Phase III Study of Cisplatin Plus Topotecan Followed by Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women With Newly Diagnosed Advanced Epithelial Ovarian Cancer.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Topotecan (Primary) ; Carboplatin; Cisplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 Apr 2020 Biomarkers information updated
- 21 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 04 Jun 2013 Final results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.